<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02984059</url>
  </required_header>
  <id_info>
    <org_study_id>The ALLAY Study</org_study_id>
    <nct_id>NCT02984059</nct_id>
  </id_info>
  <brief_title>Study Assessing Risk Factors for Abdominal Pain in Children With Inflammatory Bowel Disease</brief_title>
  <official_title>A Pilot Study Assessing Risk Factors for Abdominal Pain in Children With Inflammatory Bowel Disease: The ALLAY Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Connecticut Children's Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Connecticut Children's Medical Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      To characterize persistent abdominal pain in children with inflammatory bowel disease (IBD)&#xD;
      by examining factors such as disease type, activity and location, psychosocial factors, and&#xD;
      genetics.&#xD;
&#xD;
      The investigators hypothesize that by using patient pain and psychological assessments in&#xD;
      addition to analysis of blood, stool and colonic biopsies, we can better characterize factors&#xD;
      that predispose children and adolescents with IBD to have persistent and/or disproportionate&#xD;
      abdominal pain.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a prospective longitudinal inception cohort pilot study. The study will hopefully&#xD;
      provide information about why there is persistent abdominal pain in children with IBD by&#xD;
      examining factors such as disease type, activity and location, psychosocial factors, and&#xD;
      genetics. Fifty newly diagnosed pediatric IBD patients, age 8-17 years will be enrolled into&#xD;
      the study. There will be 2 control groups as well: pain control population: 20 patients with&#xD;
      irritable bowel syndrome (IBS) or functional abdominal pain (FAP) diagnosis who have no&#xD;
      evidence of bowel inflammation will serve as a pain control population for patients with no&#xD;
      active inflammation. To serve as a control population for patients with no abdominal pain or&#xD;
      inflammation, the investigators will include 10 patients with no gastrointestinal symptoms,&#xD;
      who undergo colonoscopy for various reasons such as painless rectal bleeding, polyp&#xD;
      surveillance, etc. The investigators anticipate completing enrollment in 12 months and&#xD;
      allowed another 12 months for follow-up.&#xD;
&#xD;
      The study participants will be seen every 3 months for a year and they will have the&#xD;
      following procedures/test performed:&#xD;
&#xD;
        1. Standard of care blood and stool samples&#xD;
&#xD;
        2. Pediatric Ulcerative Colitis Activity Index (PUCAI) or Pediatric Crohn's Disease&#xD;
           Activity Index (PCDAI)&#xD;
&#xD;
      They will have an endoscopy performed at diagnosis then at 12 months from enrollment.&#xD;
&#xD;
      A magnetic resonance enterography (MRE) will be done at diagnosis.&#xD;
&#xD;
      The following pain and anxiety tests will be performed throughout the study:&#xD;
&#xD;
      Pain:&#xD;
&#xD;
      Pain Severity Duration Scale (PSDS) Pediatric Catastrophizing Scale-Child/Parents (PCS-C/P)&#xD;
      Pain Burden Interview (PBI) Adolescent Pediatric Pain Tool (APPT)&#xD;
&#xD;
      Anxiety:&#xD;
&#xD;
      Revised Children's Anxiety and Depression Scale (RCADS-25) Children's Somatization Index&#xD;
      (CSI-24) Adult Responses to Children's Symptoms (ARCS)&#xD;
&#xD;
      Blood, rectal biopsies and stool specimens will be obtained throughout various time points of&#xD;
      the study to look at hematology, sed rates, C-reactive protein, genomic DNA, colon RNA, stool&#xD;
      microbiome and stool calprotectin.&#xD;
&#xD;
      In summary, the investigators will be examining:&#xD;
&#xD;
        1. Relationship between clinical factors and persistent abdominal pain in patients with IBD&#xD;
&#xD;
             1. Disease type&#xD;
&#xD;
             2. Location of disease at diagnosis&#xD;
&#xD;
             3. Extent of disease at diagnosis&#xD;
&#xD;
             4. Markers of inflammation at diagnosis and over the course of follow up&#xD;
&#xD;
             5. Active disease vs. inactive disease over the course of follow up&#xD;
&#xD;
        2. Relationship between psychosocial factors persistent abdominal pain, and remission&#xD;
           status, specifically in patients with:&#xD;
&#xD;
             1. Inactive IBD vs. active IBD&#xD;
&#xD;
             2. Inactive IBD vs. IBS/FAP&#xD;
&#xD;
             3. We will compare the parental report to patient report in the above mentioned groups&#xD;
&#xD;
        3. Relationship between gene expression, microbiome, persistent abdominal pain, and&#xD;
           remission status, specifically in patients with:&#xD;
&#xD;
             1. Inactive IBD vs. active IBD&#xD;
&#xD;
             2. Inactive IBD vs. IBS/FAP&#xD;
&#xD;
             3. Inactive IBD vs. controls with no abdominal pain&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">October 21, 2015</start_date>
  <completion_date type="Actual">August 1, 2018</completion_date>
  <primary_completion_date type="Actual">August 1, 2018</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Changes in abdominal pain from baseline at 3, 6, 9, and 12 months will be assessed using questionnaires</measure>
    <time_frame>Assessed at baseline then at months 3, 6, 9, and 12</time_frame>
    <description>Changes in abdominal pain from baseline then assessed again at 3, 6, 9, and 12 months.</description>
  </primary_outcome>
  <number_of_groups>3</number_of_groups>
  <enrollment type="Actual">126</enrollment>
  <condition>Inflammatory Bowel Disease</condition>
  <arm_group>
    <arm_group_label>IBD w/abdominal pain</arm_group_label>
    <description>Patients with IBD with abdominal pain. Extra colonic biopsies for RNA analysis. If blood and stool samples are collected for standard of care:blood analyzed for both genomic DNA and calprotectin, and stool analyzed for microbiome. If no blood is drawn then a buccal swab done for the genomic DNA analysis and stool analyzed for calprotectin.&#xD;
Pain questionnaires:&#xD;
Pain Frequency-Severity-Duration Scale Pain Catastrophizing Scale-Child Version Pain Burden Interview Pediatric Quality of Life Inventory Adolescent Pediatric Pain Tool Anxiety/Depression Questionnaires Revised Children's Anxiety and Depression Scale Children's Somatization Inventory Adult Responses to Children's Symptoms</description>
  </arm_group>
  <arm_group>
    <arm_group_label>IBD w/out abdominal pain</arm_group_label>
    <description>Patients with IBD and no abdominal pain. Colonoscopy done for standard of care, extra colonic biopsies for RNA analysis. If blood and stool samples are collected for standard of care:blood analyzed for genomic DNA and calprotectin and stool analyzed for microbiome. If no blood is drawn then a buccal swab for the genomic DNA analysis and stool analyzed for calprotectin.&#xD;
Pain questionnaires:&#xD;
Pain Frequency-Severity-Duration Scale Pain Catastrophizing Scale-Child Version Pain Burden Interview Pediatric Quality of Life Inventory Adolescent Pediatric Pain Tool Anxiety/Depression Questionnaires Revised Children's Anxiety and Depression Scale Children's Somatization Inventory Adult Responses to Children's Symptoms</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Colonoscopy other reasons no abd pain</arm_group_label>
    <description>Patients who have a colonoscopy for other reasons, rectal bleeding or polyp surveillance, no abdominal pain. Extra colonic biopsies for RNA analysis. If blood and stool samples are collected for standard of care:blood analyzed for genomic DNA and calprotectin and stool analyzed for microbiome. If no blood is drawn then a buccal swab for the genomic DNA analysis and stool analyzed for calprotectin.</description>
  </arm_group>
  <intervention>
    <intervention_type>Genetic</intervention_type>
    <intervention_name>Genomic DNA</intervention_name>
    <description>blood draw</description>
    <arm_group_label>Colonoscopy other reasons no abd pain</arm_group_label>
    <arm_group_label>IBD w/abdominal pain</arm_group_label>
    <arm_group_label>IBD w/out abdominal pain</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Genetic</intervention_type>
    <intervention_name>RNA analysis</intervention_name>
    <description>Mucosal Biopsy via colonoscopy</description>
    <arm_group_label>Colonoscopy other reasons no abd pain</arm_group_label>
    <arm_group_label>IBD w/abdominal pain</arm_group_label>
    <arm_group_label>IBD w/out abdominal pain</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Genetic</intervention_type>
    <intervention_name>Microbiome</intervention_name>
    <description>Stool microbiome</description>
    <arm_group_label>Colonoscopy other reasons no abd pain</arm_group_label>
    <arm_group_label>IBD w/abdominal pain</arm_group_label>
    <arm_group_label>IBD w/out abdominal pain</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Calprotectin</intervention_name>
    <description>stool or blood analysis for calprotectin</description>
    <arm_group_label>Colonoscopy other reasons no abd pain</arm_group_label>
    <arm_group_label>IBD w/abdominal pain</arm_group_label>
    <arm_group_label>IBD w/out abdominal pain</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Pain questionnaires</intervention_name>
    <description>PSDS PCS-C/P PBI APPT</description>
    <arm_group_label>IBD w/abdominal pain</arm_group_label>
    <arm_group_label>IBD w/out abdominal pain</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Anxiety/Depression Questionnaires</intervention_name>
    <description>RCADS-25 CSI-24 ARCS</description>
    <arm_group_label>IBD w/abdominal pain</arm_group_label>
    <arm_group_label>IBD w/out abdominal pain</arm_group_label>
  </intervention>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      pending&#xD;
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        The study participants will be recruited from the GI clinic here at Connecticut Children's&#xD;
        Medical Center&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Age ≥ 8 years or &lt; 18 years (achieved 8th birthday but not yet their 18th birthday)&#xD;
&#xD;
          -  IBD established by standard criteria&#xD;
&#xD;
          -  Anticipated availability for follow up for ≥ 1 year&#xD;
&#xD;
          -  Informed consent/assent&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Prior abdominal surgery unrelated to IBD&#xD;
&#xD;
          -  Active gastrointestinal infection at time of diagnosis (e.g., C. difficile)&#xD;
&#xD;
          -  Other co-morbidities that contribute to abdominal pain (e.g., Familial Mediterranean&#xD;
             Fever, metabolic disease)&#xD;
&#xD;
          -  Preexisting chronic pain disorder (e.g., fibromyalgia)&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>8 Years</minimum_age>
    <maximum_age>18 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Victoria Grossi, DO</last_name>
    <role>Principal Investigator</role>
    <affiliation>Connecticut Children's Medical Center</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>CT Children's Medical Center</name>
      <address>
        <city>Hartford</city>
        <state>Connecticut</state>
        <zip>06106</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>February 2019</verification_date>
  <study_first_submitted>February 3, 2016</study_first_submitted>
  <study_first_submitted_qc>December 2, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 6, 2016</study_first_posted>
  <last_update_submitted>February 7, 2019</last_update_submitted>
  <last_update_submitted_qc>February 7, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">February 8, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Connecticut Children's Medical Center</investigator_affiliation>
    <investigator_full_name>Victoria Grossi</investigator_full_name>
    <investigator_title>Pediatric Fellow/GI Department</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Intestinal Diseases</mesh_term>
    <mesh_term>Inflammatory Bowel Diseases</mesh_term>
    <mesh_term>Abdominal Pain</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

